Dyne Therapeutics (DYN) AI Analysis
DYN$17.16+0.15 +0.88%
Market cap$3.22BEnterprise value$2.52BRevenue (TTM)$0Market position—
Score
69
Bullish
Value
55
Quality
53
Growth
100
Dyne Therapeutics is a growth-led story right now — Growth 100/100 is the pillar doing the heavy lifting (overall 69/100) in Biotechnology. In Biotechnology, that score mix is usable but not one-dimensional. Street targets still imply ~105% upside.